242 related articles for article (PubMed ID: 30885939)
1. Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing.
Tian T; Lv X; Pan G; Lu Y; Chen W; He W; Lei X; Zhang H; Liu M; Sun S; Ou Z; Lin X; Cai L; He L; Tu Z; Wang X; Tannous BA; Ferrone S; Li J; Fan S
Clin Cancer Res; 2019 Jun; 25(12):3673-3688. PubMed ID: 30885939
[TBL] [Abstract][Full Text] [Related]
2. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1.
Fan S; Chen WX; Lv XB; Tang QL; Sun LJ; Liu BD; Zhong JL; Lin ZY; Wang YY; Li QX; Yu X; Zhang HQ; Li YL; Wen B; Zhang Z; Chen WL; Li JS
Cancer Lett; 2015 Jul; 362(2):183-91. PubMed ID: 25843291
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.
Fan S; Liu B; Sun L; Lv XB; Lin Z; Chen W; Chen W; Tang Q; Wang Y; Su Y; Jin S; Zhang D; Zhong J; Li Y; Wen B; Zhang Z; Yang P; Zhou B; Liang Q; Yu X; Zhu Y; Hu P; Chu J; Huang W; Feng Y; Peng H; Huang Q; Song E; Li J
Oncotarget; 2015 Jun; 6(17):14885-904. PubMed ID: 25912308
[TBL] [Abstract][Full Text] [Related]
4. Actin filament-associated protein 1-antisense RNA1 promotes the development and invasion of tongue squamous cell carcinoma via the AFAP1-AS1/miR-133a-5p/ZIC2 axis.
Tang M; Wu H; Zhang H; Xu X; Jiang B; Chen Q; Wei Y; Qian H; Han L
J Gene Med; 2024 Jan; 26(1):e3654. PubMed ID: 38282153
[TBL] [Abstract][Full Text] [Related]
5. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis.
Liu M; Liu Q; Fan S; Su F; Jiang C; Cai G; Wang Y; Liao G; Lei X; Chen W; Bi J; Cheng W; Zhao L; Ruan Y; Li J
Cell Death Dis; 2021 Feb; 12(2):144. PubMed ID: 33542221
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
9. LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling.
Zhang S; Ma H; Zhang D; Xie S; Wang W; Li Q; Lin Z; Wang Y
Cell Death Dis; 2018 Jul; 9(7):742. PubMed ID: 29970910
[TBL] [Abstract][Full Text] [Related]
10. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
Song K; Yu P; Zhang C; Yuan Z; Zhang H
Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
14. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
15. Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis.
Wang X; Yu H; Yu Z; Wang D
Acta Histochem; 2020 Dec; 122(8):151647. PubMed ID: 33130420
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of microRNA-17 enhances cisplatin-induced apoptosis of human tongue squamous carcinoma cell.
Sun Y; Nie W; Qiu B; Guo X; Zhang J; Wei J
J Bioenerg Biomembr; 2021 Apr; 53(2):169-176. PubMed ID: 33462751
[TBL] [Abstract][Full Text] [Related]
17. lncRNA RP5-916L7.2 correlates with advanced tumor stage, and promotes cells proliferation while inhibits cells apoptosis through targeting miR-328 and miR-939 in tongue squamous cell carcinoma.
Chen Y; Guo Y; Yan W
Clin Biochem; 2019 May; 67():24-32. PubMed ID: 30825424
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription.
Fan S; Tian T; Chen W; Lv X; Lei X; Zhang H; Sun S; Cai L; Pan G; He L; Ou Z; Lin X; Wang X; Perez MF; Tu Z; Ferrone S; Tannous BA; Li J
Cancer Res; 2019 Mar; 79(6):1069-1084. PubMed ID: 30659020
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA UCA1 regulates CCR7 expression to promote tongue squamous cell carcinoma progression by sponging miR-138-5p.
Shi TT; Li R; Zhao L
Neoplasma; 2020 Nov; 67(6):1256-1265. PubMed ID: 32749849
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
